Table 6

Odds ratios (OR) and 95% confidence intervals (CI)a between LUM SNP rs2268578 and breast cancer risk, stratified by tumor estrogen receptor status among 1,641 Caucasian subjects (Mayo Clinic 2001 to 2005) and 9,030 Caucasian subjects (SEARCH study 1990 to 2005)b

Estrogen receptor-positive

Estrogen receptor-negative



Model

Mayo Clinic sample

SEARCH sample

Pooled Mayo Clinic + SEARCH sample

Mayo Clinic sample

SEARCH sample

Pooled Mayo Clinic + SEARCH sample







Cases/controls

OR (95% CI)

Cases/controls

OR (95% CI)

OR (95% CI)

Cases/controls

OR (95% CI)

Cases/controls

OR (95% CI)

OR (95% CI)


General

0 copy

340/661

1.0 (referent)

1,506/3,506

1.0 (referent)

1.0 (referent)

86/661

1.0 (referent)

344/3,506

1.0 (referent)

1.0 (referent)

1 copy

125/167

1.5 (1.1 to 1.9)

431/980

1.0 (0.9 to 1.1)

1.1 (0.9 to 1.2)

20/167

0.9 (0.5 to 1.5)

107/980

1.0 (0.8 to 1.4)

1.0 (0.8 to 1.3)

2 copies

17/13

2.5 (1.2 to 5.3)

47/62

1.6 (1.0 to 2.5)

1.9 (1.3 to 2.8)

3/13

1.7 (0.4 to 6.5)

5/62

0.8 (0.3 to 2.0)

1.0 (0.5 to 2.2)

P valuec

0.001

0.10

0.001

0.67

0.79

0.98

Ordinal

1.5 (1.2 to 1.9)

1.1 (0.9 to 1.2)

1.1 (1.0 to 1.3)

1.0 (0.7 to 1.6)

1.0 (0.8 to 1.3)

1.0 (0.8 to 1.2)

P trend

0.0003

0.29

0.01

0.89

0.93

0.86


aMayo sample adjusted for age and region of residence (Minnesota, Iowa, Wisconsin, Illinois, North Dakota and South Dakota); SEARCH sample adjusted for age; pooled Mayo + SEARCH sample adjusted for age and study. b798 cases and 843 controls (Mayo Clinic sample), and 4,470 cases and 4,560 controls (SEARCH sample). Numbers do not total due to missing tumor status: 1,985 (44%) in SEARCH and 206 (26%) in Mayo Clinic sample. cTwo-degrees-of-freedom test.

Kelemen et al. Breast Cancer Research 2008 10:R98   doi:10.1186/bcr2201

Open Data